Effects of systemic treatment with statins on skin barrier function and stratum corneum water-holding capacity

V. Brazzelli, F. Distante, G. Perani, E. Berardesca

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: Topical application of inhibitors of HMGCoA reductase, the rate-limiting enzyme of cholesterol synthesis, has been shown to induce impairment of barrier function. Objective: Assessing whether oral administration of statins used for reducing blood levels of cholesterol induces functional changes in stratum corneum barrier. Materials and Methods: 69 subjects of both sexes undergoing treatment for hypercholesterolemia (mean age 48 ± 11 years) entered the study; 43 had been treated with simvastatin and 11 with pravastatin for 6 months; 15 only on dietary regimen served as controls. Efficiency of stratum corneum water barrier was evaluated by transepidermal water loss (TEWL) measurement using an evaporimeter; water-holding capacity of the stratum corneum was assessed by the sorption-desorption test measured by capacitance. Statistical analysis was performed using ANOVA. Results: No differences were found between the groups (simvastatin, pravastatin, diet) concerning both basal TEWL and the dynamic of water binding in the stratum corneum. Conclusions: Prolonged treatment with cholesterol-lowering drugs based on inhibition of HMGCoA reductase does not alter the permeability barrier of the skin.

Original languageEnglish
Pages (from-to)214-216
Number of pages3
JournalDermatology
Volume192
Issue number3
Publication statusPublished - 1996

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Cornea
Skin
Water
Pravastatin
Simvastatin
Cholesterol
Oxidoreductases
Therapeutics
Hypercholesterolemia
Oral Administration
Permeability
Analysis of Variance
Diet
Enzymes
Pharmaceutical Preparations

Keywords

  • Cholesterol synthesis
  • HMG-CoA reductase
  • Skin barrier function
  • Statins
  • Transepidermal water loss
  • Water-holding capacity

ASJC Scopus subject areas

  • Dermatology

Cite this

Effects of systemic treatment with statins on skin barrier function and stratum corneum water-holding capacity. / Brazzelli, V.; Distante, F.; Perani, G.; Berardesca, E.

In: Dermatology, Vol. 192, No. 3, 1996, p. 214-216.

Research output: Contribution to journalArticle

@article{d0912415b8bf4a81838b2d1cf0442af4,
title = "Effects of systemic treatment with statins on skin barrier function and stratum corneum water-holding capacity",
abstract = "Background: Topical application of inhibitors of HMGCoA reductase, the rate-limiting enzyme of cholesterol synthesis, has been shown to induce impairment of barrier function. Objective: Assessing whether oral administration of statins used for reducing blood levels of cholesterol induces functional changes in stratum corneum barrier. Materials and Methods: 69 subjects of both sexes undergoing treatment for hypercholesterolemia (mean age 48 ± 11 years) entered the study; 43 had been treated with simvastatin and 11 with pravastatin for 6 months; 15 only on dietary regimen served as controls. Efficiency of stratum corneum water barrier was evaluated by transepidermal water loss (TEWL) measurement using an evaporimeter; water-holding capacity of the stratum corneum was assessed by the sorption-desorption test measured by capacitance. Statistical analysis was performed using ANOVA. Results: No differences were found between the groups (simvastatin, pravastatin, diet) concerning both basal TEWL and the dynamic of water binding in the stratum corneum. Conclusions: Prolonged treatment with cholesterol-lowering drugs based on inhibition of HMGCoA reductase does not alter the permeability barrier of the skin.",
keywords = "Cholesterol synthesis, HMG-CoA reductase, Skin barrier function, Statins, Transepidermal water loss, Water-holding capacity",
author = "V. Brazzelli and F. Distante and G. Perani and E. Berardesca",
year = "1996",
language = "English",
volume = "192",
pages = "214--216",
journal = "Dermatology",
issn = "1018-8665",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Effects of systemic treatment with statins on skin barrier function and stratum corneum water-holding capacity

AU - Brazzelli, V.

AU - Distante, F.

AU - Perani, G.

AU - Berardesca, E.

PY - 1996

Y1 - 1996

N2 - Background: Topical application of inhibitors of HMGCoA reductase, the rate-limiting enzyme of cholesterol synthesis, has been shown to induce impairment of barrier function. Objective: Assessing whether oral administration of statins used for reducing blood levels of cholesterol induces functional changes in stratum corneum barrier. Materials and Methods: 69 subjects of both sexes undergoing treatment for hypercholesterolemia (mean age 48 ± 11 years) entered the study; 43 had been treated with simvastatin and 11 with pravastatin for 6 months; 15 only on dietary regimen served as controls. Efficiency of stratum corneum water barrier was evaluated by transepidermal water loss (TEWL) measurement using an evaporimeter; water-holding capacity of the stratum corneum was assessed by the sorption-desorption test measured by capacitance. Statistical analysis was performed using ANOVA. Results: No differences were found between the groups (simvastatin, pravastatin, diet) concerning both basal TEWL and the dynamic of water binding in the stratum corneum. Conclusions: Prolonged treatment with cholesterol-lowering drugs based on inhibition of HMGCoA reductase does not alter the permeability barrier of the skin.

AB - Background: Topical application of inhibitors of HMGCoA reductase, the rate-limiting enzyme of cholesterol synthesis, has been shown to induce impairment of barrier function. Objective: Assessing whether oral administration of statins used for reducing blood levels of cholesterol induces functional changes in stratum corneum barrier. Materials and Methods: 69 subjects of both sexes undergoing treatment for hypercholesterolemia (mean age 48 ± 11 years) entered the study; 43 had been treated with simvastatin and 11 with pravastatin for 6 months; 15 only on dietary regimen served as controls. Efficiency of stratum corneum water barrier was evaluated by transepidermal water loss (TEWL) measurement using an evaporimeter; water-holding capacity of the stratum corneum was assessed by the sorption-desorption test measured by capacitance. Statistical analysis was performed using ANOVA. Results: No differences were found between the groups (simvastatin, pravastatin, diet) concerning both basal TEWL and the dynamic of water binding in the stratum corneum. Conclusions: Prolonged treatment with cholesterol-lowering drugs based on inhibition of HMGCoA reductase does not alter the permeability barrier of the skin.

KW - Cholesterol synthesis

KW - HMG-CoA reductase

KW - Skin barrier function

KW - Statins

KW - Transepidermal water loss

KW - Water-holding capacity

UR - http://www.scopus.com/inward/record.url?scp=0029988444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029988444&partnerID=8YFLogxK

M3 - Article

C2 - 8726633

AN - SCOPUS:0029988444

VL - 192

SP - 214

EP - 216

JO - Dermatology

JF - Dermatology

SN - 1018-8665

IS - 3

ER -